Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Eli Lilly & Co (LLY) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Eli Lilly & Co. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 59478.
Total stock buying since 2015: $8,218,370.
Total stock sales since 2015: $23,196,371,694.
Total stock option exercises since 2015: $14,061,172.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 6,987 | $4,537,241 | 1,163,250 | $4,554,322,244 | 17,390 | $0 |
| 2024 | 0 | $0 | 2,879,232 | $2,352,513,879 | 16,479 | $0 |
| 2023 | 0 | $0 | 3,210,312 | $11,902,712,132 | 128,773 | $0 |
| 2022 | 858 | $249,397 | 4,522,320 | $1,397,922,981 | 66,315 | $0 |
| 2021 | 1,366 | $249,793 | 3,428,533 | $800,353,310 | 168,003 | $0 |
| 2020 | 0 | $0 | 3,592,018 | $542,331,593 | 120,374 | $0 |
| 2019 | 14,016 | $1,522,398 | 3,603,616 | $436,202,568 | 78,579 | $0 |
| 2018 | 12,168 | $1,068,636 | 5,179,358 | $521,807,695 | 261,952 | $0 |
| 2017 | 0 | $0 | 2,407,515 | $200,673,199 | 183,310 | $0 |
| 2016 | 7,605 | $590,905 | 2,352,371 | $183,183,419 | 201,412 | $0 |
| 2015 | 0 | $0 | 3,775,670 | $304,348,674 | 433,658 | $14,061,172 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-11-12 | Lilly Endowment Inc (10% Owner) | Sale | 7,981 | 114.00 | 909,841 |
| 2019-11-11 | Lilly Endowment Inc (10% Owner) | Sale | 100 | 114.06 | 11,406 |
| 2019-11-07 | Lilly Endowment Inc (10% Owner) | Sale | 400 | 114.37 | 45,749 |
| 2019-11-06 | Lilly Endowment Inc (10% Owner) | Sale | 173,918 | 114.05 | 19,835,000 |
| 2019-11-04 | Lilly Endowment Inc (10% Owner) | Sale | 7,003 | 114.04 | 798,608 |
| 2019-10-31 | Lilly Endowment Inc (10% Owner) | Sale | 190,000 | 114.27 | 21,710,350 |
| 2019-10-25 | White Anne E. (SVP & Pres-Lilly Oncology) | Buy | 1,000 | 108.84 | 108,840 |
| 2019-10-25 | Skovronsky Daniel (SVP, CSO, and Pres. LRL) | Buy | 5,000 | 108.61 | 543,050 |
| 2019-10-25 | Smiley Joshua L (SVP and CFO) | Buy | 929 | 107.59 | 99,951 |
| 2019-10-25 | Ricks David A (President & CEO) | Buy | 4,615 | 108.38 | 500,173 |
| 2019-10-24 | Tai Jackson P | Buy | 1,861 | 107.49 | 200,038 |
| 2019-09-20 | Zulueta Alfonso G (SVP & President, Lilly Int'l) | Sale | 4,500 | 117.00 | 526,500 |
| 2019-09-20 | Lilly Endowment Inc (10% Owner) | Sale | 210,000 | 116.39 | 24,441,480 |
| 2019-09-05 | Fry Stephen F (SVP, HR & Diversity) | Sale | 9,452 | 115.00 | 1,086,980 |
| 2019-09-03 | Zulueta Alfonso G (SVP & President, Lilly Int'l) | Sale | 19,500 | 112.91 | 2,201,745 |
| 2019-07-15 | Smiley Joshua L (SVP and CFO) | Buy | 185 | 108.47 | 20,066 |
| 2019-07-05 | Pusey Leigh Ann (SVP, Corp. Affairs & Comm.) | Option Ex | 2,394 | .00 | 0 |
| 2019-06-05 | Smiley Joshua L (SVP and CFO) | Buy | 426 | 118.03 | 50,280 |
| 2019-06-03 | Harrington Michael J (Senior VP and General Counsel) | Sale | 16,000 | 116.72 | 1,867,520 |
| 2019-05-03 | Shaw Christi (SVP and Pres., Lilly Bio-Meds) | Sale | 7,577 | 117.53 | 890,562 |
| 2019-05-01 | Shaw Christi (SVP and Pres., Lilly Bio-Meds) | Option Ex | 13,750 | .00 | 0 |
| 2019-04-12 | Zulueta Alfonso G (SVP & President, Lilly Int'l) | Sale | 10,000 | 124.65 | 1,246,500 |
| 2019-04-12 | Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) | Sale | 4,735 | 125.15 | 592,585 |
| 2019-04-05 | Shah Aarti S. (SVP & CIO) | Sale | 1,800 | 125.85 | 226,530 |
| 2019-03-26 | Lilly Endowment Inc (10% Owner) | Sale | 205,000 | 131.71 | 26,999,935 |
| 2019-03-22 | Zakrowski Donald A (Chief Accounting Officer) | Sale | 1,000 | 128.50 | 128,500 |
| 2019-03-12 | Fry Stephen F (SVP, HR & Diversity) | Sale | 14,847 | 123.16 | 1,828,556 |
| 2019-03-01 | Zakrowski Donald A (Chief Accounting Officer) | Sale | 1,000 | 127.01 | 127,010 |
| 2019-03-01 | Lilly Endowment Inc (10% Owner) | Sale | 210,000 | 128.32 | 26,947,830 |
| 2019-02-28 | Lilly Endowment Inc (10% Owner) | Sale | 200,000 | 127.02 | 25,403,400 |
| 2019-02-22 | Lilly Endowment Inc (10% Owner) | Sale | 195,000 | 124.19 | 24,217,635 |
| 2019-02-19 | Lilly Endowment Inc (10% Owner) | Sale | 205,000 | 122.77 | 25,168,055 |
| 2019-02-16 | Norton Johna (Senior VP, Global Quality) | Option Ex | 48 | .00 | 0 |
| 2019-02-15 | Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA) | Sale | 25,000 | 121.00 | 3,025,000 |
| 2019-02-01 | O'neill Myles (SVP & Pres., Mfg. Operations) | Option Ex | 3,221 | .00 | 0 |
| 2019-02-01 | Zulueta Alfonso G (SVP & President, Lilly Int'l) | Option Ex | 9,722 | .00 | 0 |
| 2019-02-01 | Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) | Option Ex | 3,333 | .00 | 0 |
| 2019-02-01 | Harrington Michael J (Senior VP and General Counsel) | Option Ex | 12,778 | .00 | 0 |
| 2019-02-01 | Ricks David A (President & CEO) | Option Ex | 12,222 | .00 | 0 |
| 2019-02-01 | Fry Stephen F (SVP, HR & Diversity) | Option Ex | 8,889 | .00 | 0 |
| 2019-02-01 | Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA) | Option Ex | 12,222 | .00 | 0 |
| 2019-01-31 | Zulueta Alfonso G (SVP & President, Lilly Int'l) | Sale | 4,000 | 120.00 | 480,000 |
| 2019-01-17 | Lilly Endowment Inc (10% Owner) | Sale | 136,577 | 118.47 | 16,180,823 |
| 2019-01-16 | Lilly Endowment Inc (10% Owner) | Sale | 1,657 | 117.87 | 195,315 |
| 2019-01-15 | Lilly Endowment Inc (10% Owner) | Sale | 51,766 | 117.74 | 6,095,135 |
| 2018-12-10 | O'neill Myles (SVP & Pres., Mfg. Operations) | Sale | 25,000 | 113.16 | 2,828,875 |
| 2018-12-04 | Lilly Endowment Inc (10% Owner) | Sale | 15,500 | 119.00 | 1,844,531 |
| 2018-12-02 | White Anne E. (SVP & Pres-Lilly Oncology) | Option Ex | 7,500 | .00 | 0 |
| 2018-11-29 | Lilly Endowment Inc (10% Owner) | Sale | 185,000 | 117.65 | 21,765,990 |
| 2018-11-28 | Lilly Endowment Inc (10% Owner) | Sale | 190,000 | 115.57 | 21,957,920 |
| 2018-11-19 | Lilly Endowment Inc (10% Owner) | Sale | 195,000 | 115.30 | 22,484,085 |
| 2018-11-16 | Lilly Endowment Inc (10% Owner) | Sale | 200,000 | 113.73 | 22,747,000 |
| 2018-11-13 | Lilly Endowment Inc (10% Owner) | Sale | 2,460 | 113.41 | 278,978 |
| 2018-11-12 | Lilly Endowment Inc (10% Owner) | Sale | 202,540 | 113.92 | 23,072,546 |
| 2018-11-03 | Norton Johna (Senior VP, Global Quality) | Option Ex | 3,133 | .00 | 0 |
| 2018-10-17 | Lilly Endowment Inc (10% Owner) | Sale | 174,696 | 113.25 | 19,783,623 |
| 2018-10-09 | Lilly Endowment Inc (10% Owner) | Sale | 10,672 | 115.91 | 1,237,012 |
| 2018-10-08 | Lilly Endowment Inc (10% Owner) | Sale | 14,632 | 115.91 | 1,696,039 |
| 2018-10-04 | Zulueta Alfonso G (SVP & President, Lilly Int'l) | Sale | 7,000 | 114.64 | 802,480 |
| 2018-10-04 | Lilly Endowment Inc (10% Owner) | Sale | 116,038 | 113.68 | 13,191,083 |
| 2018-10-03 | Lilly Endowment Inc (10% Owner) | Sale | 78,962 | 109.00 | 8,607,252 |
| 2018-09-28 | Lilly Endowment Inc (10% Owner) | Sale | 107,553 | 107.31 | 11,541,082 |
| 2018-09-27 | Lilly Endowment Inc (10% Owner) | Sale | 92,447 | 107.00 | 9,891,644 |
| 2018-09-26 | Lilly Endowment Inc (10% Owner) | Sale | 134,410 | 106.97 | 14,377,972 |
| 2018-09-25 | Lilly Endowment Inc (10% Owner) | Sale | 55,590 | 106.41 | 5,915,165 |
| 2018-09-18 | Zulueta Alfonso G (SVP & President, Lilly Int'l) | Sale | 3,000 | 107.00 | 321,000 |
| 2018-09-17 | Zulueta Alfonso G (SVP & President, Lilly Int'l) | Sale | 3,000 | 105.61 | 316,830 |
| 2018-09-07 | Lilly Endowment Inc (10% Owner) | Sale | 180,000 | 106.87 | 19,237,140 |
| 2018-09-04 | Zakrowski Donald A (Chief Accounting Officer) | Sale | 600 | 105.57 | 63,341 |
| 2018-08-30 | Lilly Endowment Inc (10% Owner) | Sale | 190,000 | 105.42 | 20,030,370 |
| 2018-08-20 | Lilly Endowment Inc (10% Owner) | Sale | 195,000 | 105.89 | 20,647,575 |
| 2018-08-16 | Lilly Endowment Inc (10% Owner) | Sale | 200,000 | 104.50 | 20,899,800 |
| 2018-08-15 | Lilly Endowment Inc (10% Owner) | Sale | 151,793 | 103.23 | 15,669,439 |
| 2018-08-10 | Lilly Endowment Inc (10% Owner) | Sale | 3,587 | 103.06 | 369,676 |
| 2018-08-07 | Lilly Endowment Inc (10% Owner) | Sale | 24,620 | 103.22 | 2,541,325 |
| 2018-08-06 | Lilly Endowment Inc (10% Owner) | Sale | 195,000 | 102.15 | 19,918,860 |
| 2018-08-02 | Lilly Endowment Inc (10% Owner) | Sale | 190,000 | 99.85 | 18,971,880 |
| 2018-07-31 | Lilly Endowment Inc (10% Owner) | Sale | 205,000 | 98.94 | 20,282,290 |
| 2018-07-26 | Tai Jackson P | Buy | 2,168 | 95.22 | 206,436 |
| 2018-07-25 | Lilly Endowment Inc (10% Owner) | Sale | 190,000 | 95.13 | 18,075,080 |
| 2018-07-24 | Lilly Endowment Inc (10% Owner) | Sale | 185,000 | 92.19 | 17,055,335 |
| 2018-07-06 | Lilly Endowment Inc (10% Owner) | Sale | 180,000 | 87.44 | 15,738,300 |
| 2018-07-05 | Pusey Leigh Ann (SVP, Corp. Affairs & Comm.) | Option Ex | 2,394 | .00 | 0 |
| 2018-07-05 | Lilly Endowment Inc (10% Owner) | Sale | 170,000 | 86.62 | 14,725,740 |
| 2018-06-15 | Lilly Endowment Inc (10% Owner) | Sale | 180,000 | 86.65 | 15,597,720 |
| 2018-06-14 | Skovronsky Daniel (SVP, CSO, and Pres. LRL) | Buy | 10,000 | 86.22 | 862,200 |
| 2018-06-14 | Lilly Endowment Inc (10% Owner) | Sale | 107,698 | 86.31 | 9,295,414 |
| 2018-06-13 | Lilly Endowment Inc (10% Owner) | Sale | 11,104 | 86.27 | 957,953 |
| 2018-06-11 | Lilly Endowment Inc (10% Owner) | Sale | 51,198 | 86.38 | 4,422,636 |
| 2018-06-04 | Lilly Endowment Inc (10% Owner) | Sale | 135,478 | 85.12 | 11,532,564 |
| 2018-06-01 | Lilly Endowment Inc (10% Owner) | Sale | 39,522 | 85.31 | 3,371,661 |
| 2018-05-31 | Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA) | Sale | 25,000 | 85.00 | 2,125,000 |
| 2018-05-30 | Lilly Endowment Inc (10% Owner) | Sale | 180,000 | 83.85 | 15,092,640 |
| 2018-05-29 | Shaw Christi (SVP and Pres., Lilly Bio-Meds) | Sale | 8,426 | 82.10 | 691,774 |
| 2018-05-11 | Lilly Endowment Inc (10% Owner) | Sale | 140,000 | 81.97 | 11,475,940 |
| 2018-05-03 | Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) | Sale | 9,027 | 78.50 | 708,619 |
| 2018-05-01 | Shaw Christi (SVP and Pres., Lilly Bio-Meds) | Option Ex | 13,750 | .00 | 0 |
| 2018-05-01 | Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) | Option Ex | 20,000 | .00 | 0 |
| 2018-05-01 | Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA) | Option Ex | 20,000 | .00 | 0 |
| 2018-04-25 | Lilly Endowment Inc (10% Owner) | Sale | 180,000 | 81.21 | 14,617,799 |
| 2018-04-16 | Mahony Susan (SVP & Pres., Lilly Oncology) | Sale | 17,379 | 80.08 | 1,391,710 |
| 2018-04-13 | Mahony Susan (SVP & Pres., Lilly Oncology) | Sale | 5,165 | 80.14 | 413,923 |
| 2018-03-16 | Smiley Joshua L (SVP and CFO) | Sale | 3,000 | 79.20 | 237,600 |
| 2018-03-01 | Zakrowski Donald A (Chief Accounting Officer) | Sale | 860 | 76.50 | 65,790 |
| 2018-02-21 | Zakrowski Donald A (Chief Accounting Officer) | Sale | 876 | 77.55 | 67,933 |
| 2018-02-16 | Norton Johna (Senior VP, Global Quality) | Option Ex | 48 | .00 | 0 |
| 2018-02-05 | Zakrowski Donald A (Chief Accounting Officer) | Sale | 900 | 81.09 | 72,981 |
| 2018-02-05 | Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) | Sale | 9,625 | 81.12 | 780,780 |
| 2018-02-01 | O'neill Myles (SVP & Pres., Mfg. Operations) | Option Ex | 9,596 | .00 | 0 |
| 2018-02-01 | Zulueta Alfonso G (SVP & President, Lilly Int'l) | Option Ex | 15,993 | .00 | 0 |
| 2018-02-01 | Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) | Option Ex | 6,398 | .00 | 0 |
| 2018-02-01 | Harrington Michael J (Senior VP and General Counsel) | Option Ex | 24,524 | .00 | 0 |
| 2018-02-01 | Ricks David A (President & CEO) | Option Ex | 21,326 | .00 | 0 |
| 2018-02-01 | Fry Stephen F (SVP, HR & Diversity) | Option Ex | 17,060 | .00 | 0 |
| 2018-02-01 | Lundberg Jan M (EVP,Science&Tech and Pres. LRL) | Option Ex | 36,252 | .00 | 0 |
| 2018-02-01 | Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) | Option Ex | 21,326 | .00 | 0 |
| 2018-02-01 | Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA) | Option Ex | 21,326 | .00 | 0 |
| 2018-02-01 | Mahony Susan (SVP & Pres., Lilly Oncology) | Option Ex | 21,326 | .00 | 0 |
| 2017-12-13 | Lilly Endowment Inc (10% Owner) | Sale | 200,000 | 88.53 | 17,705,200 |
| 2017-12-11 | Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) | Sale | 12,500 | 86.46 | 1,080,750 |
| 2017-12-04 | Zulueta Alfonso G (SVP & President, Lilly Int'l) | Sale | 3,532 | 86.00 | 303,752 |
| 2017-12-04 | Mahony Susan (SVP & Pres., Lilly Oncology) | Sale | 36,585 | 86.18 | 3,152,895 |
| 2017-12-03 | Zakrowski Donald A (Chief Accounting Officer) | Option Ex | 3,281 | .00 | 0 |
| 2017-12-03 | Ricks David A (President & CEO) | Option Ex | 5,496 | .00 | 0 |
| 2017-12-03 | Fry Stephen F (SVP, HR & Diversity) | Option Ex | 7,557 | .00 | 0 |
| 2017-11-10 | Zulueta Alfonso G (SVP & President, Lilly Int'l) | Sale | 2,003 | 83.67 | 167,591 |
| 2017-10-04 | Lilly Endowment Inc (10% Owner) | Sale | 205,000 | 86.81 | 17,795,025 |
| 2017-09-29 | Lilly Endowment Inc (10% Owner) | Sale | 195,000 | 85.28 | 16,630,185 |
| 2017-09-15 | Lilly Endowment Inc (10% Owner) | Sale | 190,000 | 82.91 | 15,752,710 |
| 2017-08-31 | Lilly Endowment Inc (10% Owner) | Sale | 180,000 | 81.06 | 14,590,080 |
| 2017-07-31 | Lilly Endowment Inc (10% Owner) | Sale | 220,000 | 83.38 | 18,343,820 |
| 2017-06-22 | Lilly Endowment Inc (10% Owner) | Sale | 210,000 | 84.43 | 17,730,720 |
| 2017-06-20 | Lilly Endowment Inc (10% Owner) | Sale | 215,000 | 83.05 | 17,855,320 |
| 2017-06-12 | Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) | Sale | 1,900 | 80.78 | 153,482 |
| 2017-06-09 | Harrington Michael J (Senior VP and General Counsel) | Sale | 22,833 | 79.97 | 1,825,955 |
| 2017-05-04 | Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA) | Sale | 25,000 | 82.76 | 2,069,000 |
| 2017-03-30 | Lilly Endowment Inc (10% Owner) | Sale | 210,000 | 84.67 | 17,781,540 |
| 2017-02-17 | Lilly Endowment Inc (10% Owner) | Sale | 230,000 | 80.27 | 18,462,790 |
| 2017-02-06 | Zulueta Alfonso G (SVP& Pres., Emerging Markets) | Sale | 15,000 | 77.66 | 1,164,900 |
| 2017-02-03 | Rice Derica W (EVP-Global Services and CFO) | Sale | 3,892 | 77.47 | 301,513 |
| 2017-02-02 | Zakrowski Donald A (Chief Accounting Officer) | Sale | 2,000 | 77.52 | 155,040 |
| 2017-02-02 | Rice Derica W (EVP-Global Services and CFO) | Sale | 7,270 | 76.97 | 559,571 |
| 2017-02-01 | Zulueta Alfonso G (SVP& Pres., Emerging Markets) | Option Ex | 6,659 | .00 | 0 |
| 2017-02-01 | Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) | Option Ex | 3,073 | .00 | 0 |
| 2017-02-01 | Harrington Michael J (Senior VP and General Counsel) | Option Ex | 9,732 | .00 | 0 |
| 2017-02-01 | Ricks David A (President & CEO) | Option Ex | 10,244 | .00 | 0 |
| 2017-02-01 | Crowe Maria A (President, Mfg. Operations) | Option Ex | 8,195 | .00 | 0 |
| 2017-02-01 | Walsh Fionnuala M (SVP, Global Quality) | Option Ex | 4,610 | .00 | 0 |
| 2017-02-01 | Fry Stephen F (SVP, HR & Diversity) | Option Ex | 7,683 | .00 | 0 |
| 2017-02-01 | Lundberg Jan M (EVP,Science&Tech and Pres. LRL) | Option Ex | 15,366 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of LLY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Eli Lilly & Co (symbol LLY, CIK number 59478) see the Securities and Exchange Commission (SEC) website.